Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer

(2018) Takahiro Kinoshita et al.   ANNALS OF SURGERY

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer

(2018) Guoxiu Wang et al.   BMC CANCER

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer

(2018) Dana Wai Yi Tsui et al.   EMBO Molecular Medicine

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

(2018) Jeanne Tie et al.   GUT

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

(2018) Seung Tae Kim et al.   NATURE MEDICINE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer

(2018) De-Shen Wang et al.   GUT

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab

(2018) David R. Gandara et al.   NATURE MEDICINE

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

(2018) Jingying Nong et al.   Nature Communications

Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies

(2018) Arvind Dasari et al.   JOURNAL OF CLINICAL ONCOLOGY

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

(2017) Christopher Abbosh et al.   NATURE

Direct detection of early-stage cancers using circulating tumor DNA

(2017) Jillian Phallen et al.   Science Translational Medicine

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

(2017) Aadel A. Chaudhuri et al.   Cancer Discovery

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

(2016) Jeanne Tie et al.   Science Translational Medicine

Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis

(2016) Yunhe Gao et al.   Oncotarget

Factors Associated With Recurrence and Survival in Lymph Node–negative Gastric Adenocarcinoma

(2015) Linda X. Jin et al.   ANNALS OF SURGERY

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

(2015) Isaac Garcia-Murillas et al.   Science Translational Medicine

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

Comprehensive molecular characterization of gastric adenocarcinoma

(2014) Adam J. Bass et al.   NATURE

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

(2013) Kristian Cibulskis et al.   NATURE BIOTECHNOLOGY

CONTRA: copy number analysis for targeted resequencing

(2012) Jason Li et al.   BIOINFORMATICS

Treatment of resectable gastric cancer

(2011) Johan L. Dikken et al.   Therapeutic Advances in Gastroenterology

Recurrence After Curative Resection of Early Gastric Cancer

(2009) Ho Geun Youn et al.   ANNALS OF SURGICAL ONCOLOGY